![The clinical trials at Burjeel Medical City could offer new hope for thalassaemia patients. Photo: Abu Dhabi Media Office](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/VTT7XMES6RHX7DJF27JOKYOF6I.jpg?smart=true&auth=4da5ea0eb97cdf2127dff6f088de914993c3226a89aded60de2e3949539d058e&width=400&height=225)
The clinical trials at Burjeel Medical City could offer new hope for thalassaemia patients. Photo: Abu Dhabi Media Office
The clinical trials at Burjeel Medical City could offer new hope for thalassaemia patients. Photo: Abu Dhabi Media Office
Thalassaemia trials aim to reduce burden of blood transfusions for patients
Abu Dhabi's Burjeel Medical City will assess the effectiveness and safety of Mitapivat, a drug that has shown promise in treating the blood disorder